Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence ( AI ) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing . Flu vaccine were around 48 % effective during the 2016 - 2017 season , according to the US Centers for vaccine Control . The two firms are working to combine that figure with personalised vaccine developed using a combination of ' multi - omic ' molecular data and technology .
Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence (AI) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing. Flu vaccines were around 48% effective during the 2016-2017 season, according to the US Centers for Disease Control. The two firms are hoping to improve that figure with personalised vaccines developed using a combination of 'multi-omic' molecular data and AI.